Cross-Sectional and Longitudinal Natural History of CLN3 Disease Progression

被引：0
|
作者：
Masten, Margaux C. [1 ]
Vermilion, Jennifer [1 ]
Adams, Heather R. [1 ]
Vierhile, Amy [1 ]
Marshall, Frederick J. [1 ]
Beck, Christopher A. [1 ]
Mink, Jonathan W. [1 ]
Augustine, Erika F. [1 ]
机构：
[1] Univ Rochester, Rochester, NY USA
来源：
ANNALS OF NEUROLOGY | 2020年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
134
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 50 条
  • [41] Novel morphological macular findings in juvenile CLN3 disease
    Dulz, S.
    Wagenfeld, L.
    Nickel, M.
    Richard, G.
    Schwartz, R.
    Bartsch, U.
    Kohlschuetter, A.
    Schulz, A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (06) : 824 - 828
  • [42] The 50-meter timed test as a longitudinal functional outcome measure in CLN3 Batten disease
    Abreu, N. J.
    Powers, B. P.
    Yildiz, V
    Sveda, M.
    Peifer, D.
    Khuhro, Z.
    O'Neal, M.
    Alfano, L.
    Scherr, J.
    de los Reyes, E.
    ANNALS OF NEUROLOGY, 2025, 96 : S124 - S125
  • [43] Motor function impairment is an early sign of CLN3 disease
    Kuper, Willemijn F. E.
    van Alfen, Claudia
    van Eck, Linda
    Huijgen, Barbara C. H.
    Nieuwenhuis, Edward E. S.
    van Brussel, Marco
    van Hasselt, Peter M.
    NEUROLOGY, 2019, 93 (03) : E293 - E297
  • [44] Drug-induced hyperthermia with rhabdomyolysis in CLN3 disease
    Savvidou, A.
    Jennions, E.
    Wikstrom, S.
    Olsson-Engman, M.
    Sofou, K.
    Darin, N.
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2022, 39 : 74 - 78
  • [45] Membrane topology of CLN3, the protein underlying Batten disease
    Mao, QW
    Foster, BJ
    Xia, HB
    Davidson, BL
    FEBS LETTERS, 2003, 541 (1-3) : 40 - 46
  • [46] Evidence for phosphorylation of CLN3 protein associated with Batten disease
    Michalewski, MP
    Kaczmarski, W
    Golabek, AA
    Kida, E
    Kaczmarski, A
    Wisniewski, KE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (02) : 458 - 462
  • [47] Recognizing differentiating clinical signs of CLN3 disease (Batten disease) at presentation
    Kuper, Willemijn F. E.
    Talsma, Herman E.
    van Schooneveld, Mary J.
    Pott, Jan Willem R.
    Huijgen, Barbara C. H.
    de Wit, Gerard C.
    van Hasselt, Peter M.
    van Genderen, Maria M.
    ACTA OPHTHALMOLOGICA, 2021, 99 (04) : 397 - 404
  • [48] Tissue expression and subcellular localization of CLN3, the Batten disease protein
    Margraf, LR
    Boriack, RL
    Routheut, AAJ
    Cuppen, I
    Alhilali, L
    Bennett, CJ
    Bennett, MJ
    MOLECULAR GENETICS AND METABOLISM, 1999, 66 (04) : 283 - 289
  • [49] Clinical and genetic factors associated with contralateral progression in unilateral moyamoya disease: Longitudinal and Cross-Sectional Study
    Wang, Xiao-Peng
    Zou, Zheng-Xing
    Bao, Xiang -Yang
    Wang, Qian-Nan
    Ren, Bin
    Yu, Dan
    Zhang, Qian
    Liu, Jia-Qi
    Hao, Fang -Bin
    Gao, Gan
    Guo, Qing-Bao
    Fu, He-Guan
    Li, Jing-Jie
    Wang, Min-Jie
    Liu, Si -Meng
    Duan, Lian
    HELIYON, 2024, 10 (04)
  • [50] Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease
    Järvelä, I
    Sainio, M
    Rantamäki, T
    Olkkonen, VM
    Carpén, O
    Peltonen, L
    Jalanko, A
    HUMAN MOLECULAR GENETICS, 1998, 7 (01) : 85 - 90
12345